Javascript must be enabled to continue!
JCPyV Infection is Highly Prevalent in UTUC: Implications for Oncogenic Factors and Pathological Staging
View through CrossRef
Abstract
Background
Upper tract urothelial carcinoma (UTUC) is a subtype of urothelial carcinoma that shares similarities with bladder cancer but is more aggressive. Human polyomaviruses (HPyVs) have been found in UTUC; however, the association of the viral large T antigen (LT) protein and the tumor suppressor protein, p53, post-infection with the clinical characteristics of UTUC remains unclear. This study aimed to investigate the prevalence of the JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV) in UTUC and their correlation with cancer progression among the southwest Taiwanese population from 2020 to 2022.
Methods
A total of 72 paraffin-embedded UTUC tissue samples and 41 adjacent normal tissue samples were collected from 72 patients. Nested polymerase chain reaction and DNA sequencing were used to detect viral DNA and genotypes. Immunohistochemistry was used to detect the expression of early protein LT and cellular p53 protein.
Results
The overall prevalence of HPyVs was higher in UTUC samples than in normal tissue samples (65.3% [47/72] vs 17.1% [7/41]). Among the UTUC samples with HPyVs, JCPyV and BKPyV were detected in 62.5% (45/47) and 2.8% (2/47) of the samples, respectively. JCPyV-TW-3 was the predominant strain of JCPyV infection. In UTUC samples, the LT protein positivity rate was 65.3%, and the p53 protein was prevalent in 45.8%. JCPyV infection increased the risk of UTUC by 9.13-fold, and this increased by another 9.13-fold with LT protein expression. The risk of UTUC was higher by 7.83-fold in those with p53 expression and by 8.58-fold in those with co-expression of LT and p53. Compared with males, females had a 5.19-fold higher probability for both JCPyV infection and LT expression. The probability of LT and p53 co-expression was 4.15-fold higher in females. Patients aged ≥ 65 years had a 2.98-fold higher probability of p53 expression. In the advanced stages, the probability of virus-induced LT expression was 3.18-fold higher, and the probability of LT and p53 co-expression was 2.86-fold higher.
Conclusions
JCPyV infection is highly prevalent in UTUC, and the concurrent high expression of LT and p53 can be a useful biomarker for treatment and prognosis.
Springer Science and Business Media LLC
Title: JCPyV Infection is Highly Prevalent in UTUC: Implications for Oncogenic Factors and Pathological Staging
Description:
Abstract
Background
Upper tract urothelial carcinoma (UTUC) is a subtype of urothelial carcinoma that shares similarities with bladder cancer but is more aggressive.
Human polyomaviruses (HPyVs) have been found in UTUC; however, the association of the viral large T antigen (LT) protein and the tumor suppressor protein, p53, post-infection with the clinical characteristics of UTUC remains unclear.
This study aimed to investigate the prevalence of the JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV) in UTUC and their correlation with cancer progression among the southwest Taiwanese population from 2020 to 2022.
Methods
A total of 72 paraffin-embedded UTUC tissue samples and 41 adjacent normal tissue samples were collected from 72 patients.
Nested polymerase chain reaction and DNA sequencing were used to detect viral DNA and genotypes.
Immunohistochemistry was used to detect the expression of early protein LT and cellular p53 protein.
Results
The overall prevalence of HPyVs was higher in UTUC samples than in normal tissue samples (65.
3% [47/72] vs 17.
1% [7/41]).
Among the UTUC samples with HPyVs, JCPyV and BKPyV were detected in 62.
5% (45/47) and 2.
8% (2/47) of the samples, respectively.
JCPyV-TW-3 was the predominant strain of JCPyV infection.
In UTUC samples, the LT protein positivity rate was 65.
3%, and the p53 protein was prevalent in 45.
8%.
JCPyV infection increased the risk of UTUC by 9.
13-fold, and this increased by another 9.
13-fold with LT protein expression.
The risk of UTUC was higher by 7.
83-fold in those with p53 expression and by 8.
58-fold in those with co-expression of LT and p53.
Compared with males, females had a 5.
19-fold higher probability for both JCPyV infection and LT expression.
The probability of LT and p53 co-expression was 4.
15-fold higher in females.
Patients aged ≥ 65 years had a 2.
98-fold higher probability of p53 expression.
In the advanced stages, the probability of virus-induced LT expression was 3.
18-fold higher, and the probability of LT and p53 co-expression was 2.
86-fold higher.
Conclusions
JCPyV infection is highly prevalent in UTUC, and the concurrent high expression of LT and p53 can be a useful biomarker for treatment and prognosis.
Related Results
Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis
Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis
AbstractBackgroundBK polyomavirus (BKPyV) can cause hemorrhagic cystitis (HC) in allogeneic hematopoietic stem cell transplant (allo‐HSCT) patients and polyomavirus‐associated neph...
Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing
Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing
BackgroundUpper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BLCA) both originate from uroepithelial tissue, sharing remarkably similar clinical manifestatio...
Long‐term endoscopic management of upper tract urothelial carcinoma: 20‐year single‐centre experience
Long‐term endoscopic management of upper tract urothelial carcinoma: 20‐year single‐centre experience
Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
...
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
What's known on the subject? and What does the study add?
Endoscopic management of upper tract urothelial carcinoma (UTUC) using either ure...
DETECÃO DE POLIOMAVIRUS HUMANOS JCVYP E BKVYP EM AMOSTRAS DE LÍQUOR DE PACIENTES COM MANIFESTAÇÕES NEUROLÓGICAS PORTADORES DO VÍRUS HIV
DETECÃO DE POLIOMAVIRUS HUMANOS JCVYP E BKVYP EM AMOSTRAS DE LÍQUOR DE PACIENTES COM MANIFESTAÇÕES NEUROLÓGICAS PORTADORES DO VÍRUS HIV
Introdução: Pessoas com HIV são propensas a infecções oportunistas por vários patógenos, inclusive vírus. Entre os vírus que podem infectar o sistema nervoso central (SNC), destaca...
Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer
Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer
ABSTRACT
Purpose
Upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB) share histomorphol...
Abstract 1737: METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma
Abstract 1737: METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma
Abstract
Upper tract urothelial carcinoma (UTUC), comprising 5% of urothelial neoplasms, is a rare malignancy arising from the transitional epithelium of the renal p...
Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial. We evaluated the effect of the involvement of urothelial bladder carcinoma (U...

